Treatments

New results implicate an enzyme called ERK in the consequences of missing a segment of chromosome 16.

In May, the U.S. Food and Drug Administration guaranteed an experimental autism drug a speedy review for approval, but some scientists are skeptical of the drug’s potential.

A huge new research collaboration may jump-start the race to develop therapies for autism.

Seizures early in life may render brain circuits incapable of supporting learning during critical developmental periods.

A miniature particle delivers the gene-editing tool CRISPR into the brains of fragile X mice.

Many clinics offer neurofeedback as a therapy for autism, despite little scientific support for the technique.